# Case-001 Clinician Confirmation Packet Index Gate

Date checked: 2026-05-22
Evidence label: clinician confirmation packet index, not medical advice

## Direct Answer

The next blocker is not another candidate claim. It is a doctor-facing packet
index that tells the clinician what to read first, what to confirm, what stays
private, and what is only appendix material.

Case-001 should use this label:

`case001_clinician_confirmation_packet_index_ready`

## Why This Matters

The main paper is a research map. It is not the first doctor-facing document.
The first packet should ask the clinician to validate labels, name missing
records, assign owner categories, and decide whether specialist screening is
ready or still data-missing.

## Source Refresh

The May 22 check did not create a new cure claim:

- TIF 2025 keeps transfusion category, transfusion burden, adverse events,
  iron overload, chelation, and monitoring as core clinical-context domains.
- GeneReviews keeps diagnosis and genotype confirmation upstream of
  patient-specific treatment relevance.
- `NCT07506863` pediatric TDT and `NCT07517133` pediatric NTDT remain
  not-yet-recruiting mitapivat records with no posted results in the May 22 API
  check.
- `NCT04770779` remains adult TDT mitapivat benchmark evidence with posted
  results, not pediatric case-specific evidence.

## Packet Order

| Step | Send or ask | Public-safe output |
| --- | --- | --- |
| `send_one_page_handoff_first` | Use the doctor handoff brief or PDF first. | `scope_confirmed_or_corrected` |
| `attach_private_original_records` | Attach original records privately, outside Git. | `private_records_attached_label_only` |
| `validate_core_labels` | Ask which working labels are correct, wrong, or not confirmable. | `labels_confirmed_corrected_or_unconfirmable` |
| `name_missing_records_and_owner` | Ask which missing records should be requested first and from whom. | `missing_record_owner_labels_only` |
| `classify_advanced_review_readiness` | Ask if specialist screening is ready, data-missing, unsuitable, blocked, or under review. | `advanced_review_readiness_label` |
| `route_mitapivat_only_after_prerequisites` | Ask the mitapivat review-readiness question only after prerequisites pass. | one allowed mitapivat response label |
| `offer_main_paper_as_appendix_only` | Use the main paper only if the clinician asks for broader evidence. | `appendix_requested_or_not_needed` |

## Stop Conditions

Stop before disease-specific treatment-lane questions if:

- diagnosis or transfusion category is unclear;
- original private records are missing from the clinician packet;
- any required label is corrected or not confirmable;
- record owner categories are unknown;
- private material has not passed release review;
- the clinician asks to handle the basic case packet before the research
  appendix.

## Biomedical Boundary

This gate does not diagnose subtype, recommend treatment, request dosing,
change transfusion or chelation, decide referral, decide trial screening, or
interpret private records. It only orders the confirmation packet.

## Islamic Motivation Boundary

Quran 49:6 supports verification before acting on reports. Quran 16:43 supports
qualified expert consultation when knowledge is missing. Quran 55:7-9 supports
measured claims and anti-exaggeration. These are research-method anchors, not
biomedical evidence.

## Sources

- [Clinician confirmation packet index map](../../../data/workflows/case-001/2026-05-22-clinician-confirmation-packet-index.json)
- [Case-001 doctor handoff brief](../case-context/case-001-doctor-handoff-brief.md)
- [Case-001 minimum hematologist packet](../case-context/case-001-minimum-hematologist-packet.md)
- [Case-001 mitapivat clinician conversation sequence](../case-context/case-001-mitapivat-clinician-conversation-sequence.md)
- [TIF 2025 blood transfusion chapter](https://www.ncbi.nlm.nih.gov/books/NBK614240/)
- [TIF 2025 iron overload chapter](https://www.ncbi.nlm.nih.gov/books/NBK614244/)
- [TIF 2025 monitoring recommendations](https://www.ncbi.nlm.nih.gov/books/NBK614248/)
- [GeneReviews beta-thalassemia](https://www.ncbi.nlm.nih.gov/books/NBK1426/)
- [ClinicalTrials.gov NCT07506863](https://clinicaltrials.gov/study/NCT07506863)
- [ClinicalTrials.gov NCT07517133](https://clinicaltrials.gov/study/NCT07517133)
- [ClinicalTrials.gov NCT04770779](https://clinicaltrials.gov/study/NCT04770779)
- [Quran 49:6 verification anchor](../../islamic/quran/049-al-hujurat/006.md)
- [Quran 16:43 expert-consultation anchor](../../islamic/quran/016-an-nahl/043.md)
- [Quran 55:7-9 mizan anchor](../../islamic/quran/055-ar-rahman/007-009.md)
